Company / Capital Expenditures
Amgen Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$1.9B
FY2025
5-year range
$880.0M / $1.9B
FY2021-FY2025
Trend
+69.5%
vs FY2024
Sector context
#4 of 192
Health Care
What the data says
Among 192 Health Care companies, Amgen is in the top 2% for capital expenditures. Capital Expenditures has fluctuated over the past 10 years, ranging from $608M in FY2020 to $1.9B in FY2025.
Based on SEC 10-K filings.
$1.9B in FY2025 with a 5-year CAGR of +25.0%. Top quartile in the Health Care sector.
Improved from $1.1B to $1.9B over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +25.7%
- 5-Year CAGR
- +25.0%
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 192This company $1.9B Sector average $118.6M
▼
+1466.7% above sector average
Key checks
Key Insights
- 5-year CAGR of +25.0%, indicating consistent growth.
- In FY2025, capital expenditures increased 69.5% year-over-year.
- Ranks #4 out of 192 companies in the Health Care sector.
- Lowest capital expenditures in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.9B | +69.5% |
| FY2024 | $1.1B | -1.4% |
| FY2023 | $1.1B | +18.8% |
| FY2022 | $936.0M | +6.4% |
| FY2021 | $880.0M | +44.7% |
| FY2020 | $608.0M | -1.6% |
| FY2019 | $618.0M | -16.3% |
| FY2018 | $738.0M | +11.1% |
| FY2017 | $664.0M | -10.0% |
| FY2016 | $738.0M | +24.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026